Page last updated: 2024-10-17

aminocaproic acid and Bone Diseases

aminocaproic acid has been researched along with Bone Diseases in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Bone Diseases: Diseases of BONES.

Research Excerpts

ExcerptRelevanceReference
"Lathyrism has been reviewed in respect to four overlapping phases: finding an animal model for neurolathyrism, characterizing osteolathyrism in respect to its possible use as an animal model for human diseases, such as Marfan's syndrome, idiopathic juvenile scoliosis, etc."1.27Lathyrism: mini-review and a comment on the lack of effect of protease inhibitors on osteolathyrism. ( Arunatut, O; Buranarugsa, MW; Yeager, VL, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yeager, VL1
Buranarugsa, MW1
Arunatut, O1

Other Studies

1 other study available for aminocaproic acid and Bone Diseases

ArticleYear
Lathyrism: mini-review and a comment on the lack of effect of protease inhibitors on osteolathyrism.
    Journal of experimental pathology, 1985,Spring, Volume: 2, Issue:1

    Topics: Aminocaproates; Aminocaproic Acid; Aminopropionitrile; Animals; Aprotinin; Bone Diseases; Collagen;

1985